Developing and investing in companies and technologies in high value emerging markets
Our focus is on developing and investing in companies and technologies in high value emerging markets, specifically Cannabis and Medical Fungi. We look for investments in operators who will become the foundational base for growth in each segment and related technologies and research assets that can support near term and future expansion.
Pervasip owns 100% of Artizen Corporation (“Artizen Corp”). Artizen Corp’s wholly owned subsidiary, Zen Asset Management LLC (“ZAM”) is a foundational operator that provides the basis for our cannabis related investments. ZAM, a diversified asset management company was founded to acquire, develop, and support companies and technologies in the cannabis industry.
We also invested in a small Korea based research entity, KRTL, to establish an early foothold in the rapidly expanding world of medical fungi, with a specific focus on Psilocybin. It is an entry to a large database of related research, various research entities actively involved in related development projects and provides Pervasip with a perfect perch to look at various fungi opportunities across the globe.